FOXP3 and vitiligo: After initial screening, 913 studies were excluded as they contained duplicate records and did not involve assessment of Tregs' frequency, Tregs' suppressive capacity, FOXP3 levels, IL-10 levels, and TGF-β levels in vitiligo.